natgillin/translations-raw huggingface dataset:
DNA, d(P-thio) (G-A-T-C-C-G-C-G-G-G-A-A-A-T), tridecasodium salt
DNA, d(P-thio) (G-A-T-C-C-G-C-G-G-G-A-A-A-T), tridekanátrium soľ
1-(3,5-anhydro-2-deoxy-β-D-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
1-(3,5-anhydro-2-deoxy-β-D-treo-pentofuranosyl)-5-metylpyrimidín-2,4(1H,3H)-dión
1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid hydrobromide
kyselina 1,4-ditia-7-azaspiro[4.4]nonán-8-karboxylová hydrobromid
(3S)-6,6-dibromo-2,2-dimethylpenam-3-carboxylic acid 1,1-dioxide
(3S)-6,6-dibróm-2,2-dimetylpenam-3-karboxylová 1,1-dioxid
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-metyl-3-O-metyl-α-L-ribo-hexopyranosyl)oxy]-2-etyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexametyl-11-[3,4,6-trideoxy-3-(dimetylamino)-β-D-xylo-hexopyranosyl]oxy-1-oxa-6-azacyklopentadekán-15-ón
trans-(7R)-7-amino-3-vinyl-3,4-didehydrocepham-4-carboxylic acid
kyselina trans-(7R)-7-amino-3-vinyl-3,4-didehydrocefam-4-karboxylová
(4S)-4,11-diethyl-4,9-dihydroxy-1H,12H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(4S)-4,11-dietyl-4,9-dihydroxy-1H,12H-pyrano[3',4':6,7]indolizino[1,2-b]chinolín-3,14(4H,12H)-dión
N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine
N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)fenyl]glycín
diphenylmethyl (7R)-3-(mesyloxy)-7-(phenylacetamido)-3,4-didehydrocepham-4-carboxylate
difenylmetyl (7R)-3-(mesyloxy)-7-(fenylacetamido)-3,4-didehydrocefam-4-karboxylát
2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-N2-isobutyrylguanosine 3'-(2-cyanoethyl diisopropylphosphoramidite)
2'-deoxy-5'-O-(4,4’-dimetoxytrityl)-N2-izobutyrylguanozín 3'-(2-kyanoetyl diizopropylfosforamidit)
(3-aminopyrazol-4-yl)(2-thienyl)methanone
(3-aminopyrazol-4-yl)(2-tienyl)metanón
thiophene-2-carbaldehyde
tiofén-2-karbaldehyd
2'-deoxy-5'-O-(4,4'-dimethoxytrityl)thymidine 3'-(2-cyanoethyl diisopropylphosphoramidite)
2'-deoxy-5'-O-(4,4’-dimetoxytrityl)tymidín3'-(2-kyanoetyl diizopropylfosforamidit)
N6-benzoyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)adenosine 3'-(2-cyanoethyl diisopropylphosphoramidite)
N6-benzoyl-2'-deoxy-5'-O-(4,4’-dimetoxytrityl)adenozín3'-(2-kyanoetyl diizopropylfosforamidit)
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine
(2S)-2-[(S)-(2-etoxyfenoxy)fenylmetyl]morfolín
N-[3-(2-amino-1-hydroxyethyl)-4-fluorophenyl]methanesulfonamide
N-[3-(2-amino-1-hydroxyetyl)-4-fluórfenyl]metánsulfónamid
N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzene-1-sulfonamide
N-[2-(4-hydroxyanilino)pyridín-3-yl]-4-metoxybenzén-1-sulfónamid
N-(butane-1-sulfonyl)-L-tyrosine
N-(bután-1-sulfonyl)-L-tyrozín
N-(butane-1-sulfonyl)-O-(4-pyridin-4-ylbutyl)-L-tyrosine
N-(bután-1-sulfonyl)-O-(4-pyridín-4-ylbutyl)-L-tyrozín
(3S)-tetrahydrofuran-3-yl N-[(2S,3R)-3-hydroxy-4-(N-isobutyl-4-nitrobenzene-1-sulfonamido)-1-phenylbutan-2-yl]carbamate
(3S)-tetrahydrofurán-3-yl N-[(2S,3R)-3-hydroxy-4-(N-izobutyl-4-nitrobenzén-1-sulfónamid)-1-fenylbután-2-yl]karbamát
4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-isobutylbenzene-1-sulfonamide
4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-fenylbutyl]-N-izobutylbenzén-1-sulfónamid
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide
4-[5-(4-fluórfenyl)-3-(trifluórmetyl)pyrazol-1-yl]benzén-1-sulfónamid
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
N-(3-metoxy-5-metylpyrazín-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)fenyl]pyridí-3-sulfónamid
3-(2-amino-1-hydroxyethyl)-4-methoxybenzene-1-sulfonamide
3-(2-amino-1-hydroxyetyl)-4-metoxybenzén-1-sulfónamid
4-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzamido]-1-methyl-3-propylpyrazole-5-carboxamide
4-[2-etoxy-5-(4-metylpiperazín-1-sulfonyl)benzamid]-1-metyl-3-propylpyrazol-5-karboxamid
N-(1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide hydrochloride
N-(1,2,3,4-tetrahydroizochinolín-5-yl)metánsulfónamid hydrochlorid
N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzene-1-sulfonamide hydrochloride
N-((2R,3S)-3-amino-2-hydroxy-4-fenylbutyl)-N-izobutyl-4-nitrobenzén-1-sulfónamid hydrochlorid
2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl]nicotinic acid
kyselina 2-etoxy-5-(4-etylpiperazín-1-sulfonyl]nikotínová
(4R,6S)-6-((E)-2-4-(4-fluorophenyl)-6-isopropyl-2-[mesyl(methyl)amino]pyrimidin-5-ylvinyl)-2,2-dimethyl-1,3-dioxan-4-yl 3,3-dimethylbutanoate
(4R,6S)-6-((E)-2-4-(4-fluórfenyl)-6-izopropyl-2-[mesyl(metyl)amino]pyrimidín-5-ylvinyl)-2,2-dimetyl-1,3-dioxán-4-yl 3,3-dimetylbutanoát
5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,3,4,5,6,7-hexahydropyrazolo[4,3-d]pyrimidin-7-one
5-[2-etoxy-5-(4-etylpiperazín-1-sulfonyl)pyridín-3-yl]-3-etyl-2-(2-metoxyetyl)-2,3,4,5,6,7-hexahydropyrazolo[4,3-d]pyrimidín-7-ón
5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,3,4,5,6,7-hexahydropyrazolo[4,3-d]pyrimidin-7-one 4-methylbenzene-1-sulfonate
5-[2-etoxy-5-(4-etylpiperazín-1-sulfonyl)pyridín-3-yl]-3-etyl-2-(2-metoxyetyl)-2,3,4,5,6,7-hexahydropyrazolo[4,3-d]pyrimidín-7-ón 4-metylbenzén-1-sulfonát
N-[3-carbamoyl-5-ethyl-1-(2-methoxyethyl)pyrazol-4-yl]-2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]nicotinamide
N-[3-karbamoyl-5-etyl-1-(2-metoxyetyl)pyrazol-4-yl]-2-etoxy-5-[(4-etylpiperazín-1-yl)sulfonyl]nikotínamid
3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide
3-[(dimetylamino)metyl]-4-[4-(metylsulfanyl)fenoxy]benzén-1-sulfónamid
3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide L-tartarate (1:1)
3-[(dimetylamino)metyl]-4-[4-(metylsulfanyl)fenoxy]benzén-1-sulfónamid L-tartarát (1:1)
1-(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride
1-(4-hydrazinofenyl)-N-metylmetánsulfónamid hydrochlorid
mixture of sennoside A and B
zmes senozidu A a B
mixture of sennoside A and B, calcium salts
zmes senozidu A a B, vápenaté soli
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g]quinoline-10,11-diol or apomorphine
(6aR)-6-metyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g]chinolín - 10,11-diol alebo apomorfín
2-[2-methyl-1-(propionyloxy)propoxy]-2-[(4-phenylbutyl)phosphinoyl]acetic acid, (9R)-cinchonan-9-ol salt (1:1)
kyselina 2-[2-metyl-1-(propionyloxy)propoxy]-2-[(4-fenylbutyl)fosfinoyl]octová, (9R)-cinchonan 9-ol soľ (1:1)
benzyl 2,6-dimethoxy-4-(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-ylphenyl carbonate
benzyl-2,6-dimetoxy-4-(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glukopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]nafto[2,3-d][1,3]dioxol-5-ylfenyl karbonát
2,3-di-O-benzyl-4,6-O-((1R)-ethylidene)-D-xylo-hexopyranose
2,3-di-O-benzyl-4,6-O-((1R)-etylidén)-D-xylo-hexopyranóza
(5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside
(5S,5aS,9S)-9-(4-hydroxy-3,5-dimetoxyfenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]nafto[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-etylidén]-β-D-glukopyranozid
2,3,4,6-tetra-O-benzyl-D-glucopyranose
2,3,4,6-tetra-O-benzyl-D-glukopyranóza
(2S,3S,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol
(2S,3S,4R,5R)-2-(hydroxymetyl)piperidín-3,4,5-triol
dicyclohexylammmonium (7R)-3-(acetoxymethyl)-7-[2-((3R)-3-[(tert-butoxycarbonyl)amino]-3-carboxypropylamino)-2-oxoethyl]-3,4-didehydrocepham-4-carboxylate or cephalosporin D dicyclohexylamine salt
dicyklohexylamónium(7R)-3-(acetoxymetyl)-7-[2-((3R)-3-[(terc-butoxykarbonyl)amino]-3-karboxypropylamino)-2-oxoetyl]-3,4-didehydrocefam-4-karboxylát alebo cefalosporín D dicyklohexylamín soľ
Blood-coagulation factor XIVa
faktor zrážanlivosti krvi XIVa
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution
(1R)-1-[3,5-bis(trifluórmetyl)fenyl]etán-1-ol, roztok acetonitrilu
(3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution
(3S)-3-[2-(mesyloxy)etoxy]-4-(trityloxy)butyl metánsulfonát, roztok dimetylformamidu
4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution
4-(4-chlór-1,2,5-tiadiazol-3-yl)mofolín, roztok toluénu
(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution
(2S,3R)-4-(dimetylamino)-3-metyl-1,2-dfenylbután-2-ol, roztok toluénu
4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution
4-[2-(piperidín-1-yl)etoxy]benzoyl chlorid hydrochlorid, roztok 1,2-dichlóretánu
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006
Zoznam farmaceutických medziproduktov, t. j. zlúčenín používaných na výrobu konečných farmaceutických výrobkov, ktoré sa vyradia zo zoznamu výrobkov oslobodených od cla, uvedených v prílohe 6 k nariadeniu (ES) č. 1549/2006
isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(E)-(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enylcyclopentyl]hept-5-enoate
izopropyl-(Z)-7-(1R,2R,3R,5S)-3,5-dihydroxy-2-(E)-(3R)-3-hydroxy-4-[3-(trifluórmetyl)fenoxy]but-1-enylcyklopentenylhept-5-enoát
4-acetamido-2'-aminobenzanilide
4-acetamido-2„-aminobenzanilid
N-[(2,6-diisopropylphenoxy)sulfonyl]-2-(2,4,6-triisopropylphenyl)acetamide
N-[(2,6-diizopropylfenoxy)sulfonyl]-2-(2,4,6-triizopropylfenyl)etánamid
13-ethyl-17-alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
13-etyl-17a-hydroxy-18,19-dinor-4-pregnén-20-ín-3-ónoxím
2-hydroxy-4-(methylthio)butyric acid
kyselina 2-hydroxy-4-(metylsulfanyl)butánová
methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-beta-D-glucopyranuronosyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1,4)-2-deoxy-2-(sulfoamino)-6-(hydrogen sulfate)-alpha-D-glucopyranoside, decasodium salt
metyl-O-2-deoxy-6-O-sulfo-2-(sulfoamino)-a-D-glukopyranozyl-(1,4)-O-b-glukopyranuronozyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-a-D-glu-kopyranozyl-(1,4)-O-2-O-sulfo-a-L-idopyranuronosyl-(1,4)-2-deoxy-(sulfoamino)-6-(hydrogénsulfát)-a-D-glukopyranozid, dekasodná soľ
fondaparinux sodium (INN)
fondaparinux sodný (INN)
[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl](4-piperidyl)amine
N-[1-(4-fluórbenzyl)-1H-benzo[d]imidazol-2-yl](piperidín-4-yl)amín
8-chloro-11-(4-piperidylidene)-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
8-chloro-11-(piperidín-4-ylidén)-5,6-dihydro-11H-benzo[5,6]cyklohepta[1,2-b]pyridín
desloratadine (INN)
desloratadín (INN)
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide
[1-(2,4-dichlórfenyl)-5-(3-chlórfenyl)-4-metylpiperidín-1-yl]-1-H-pyrazol-3-karboxamid
4-4-[(11R)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidinocarbonylmethylpiperidine-1-carboxamide
4-4-[(11R)-3,10-dibróm-8-chlór-5,6-dihydro-11H-benzo[5,6] cyklohepta-[1,2-b]pyridín-11-yl]piperidinokarbonylmetylpiperidín-1-karboxamid
2-[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonylaminoadamantane-2-carboxylic acid
kyselina 2-[1-(7-chlór-4-chinolyl)-5-(2,6-dimetoxyfenyl)-1H-pyrazol-3-yl]karbonylamino adamantán-2-karboxylová
(R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonic acid
kyselina [(R)-2-(6-amino-9H-purín-9-yl)propán-2-oxy]metylfosfónová
6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione
6-benzyl-1-(etoxymetyl)-5-izopropyl-1,2,3,4-tetrahydropyrimidín-2,4-dión
(S)-2-(4-[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-ynyl)amino-2-fluorobenzamido)-4-(1H-tetrazol-5-yl)butyric acid
kyselina (S)-2-4-[[(2,7-dimetyl-4-oxo-1,4-dihydrochinazolín-6-yl)metyl]-(prop-2-inyl)]amino-2-fluórbenzén-karboxamido-4-(1H-tetrazol-5-yl)butánová
(+-)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
kyselina(+-)-6-fluór-1-metyl-4-oxo-7-(piperazín-1-yl)-4H-1,3-tiazeto[3,2-a]chinolín-3-karboxylová
(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmethanol
[(2R,4R)-4-(2,6-diamino-9H-purín-9-yl)-1,3-dioxolán-2-yl]metanol
4-[4-(4-4-[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethyloxy]phenylpiperazin-1-yl)phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,2,4-triazol-5(4H)-one
4-4-4-[4-[(3R,5R)-5-(2,4-difluórfenyl)-5-(1H-1,2,4-triazol-1-ylmetyl)oxolán-3-ylmetoxy]fenyl]pipe/razín-1-ylfenyl-1-[(1S,2S)-1-etyl-2-hydroxypropyl]-4,5-dihydro-1,2,4-triazol-5-ón
posaconazole (INN)
posakonazol (INN)
(3-chloro-4-fluorophenyl)[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine
3-(6-fluór-2-chlórfenyl)-5-metyl-1,2-oxazol-4-karbonylchlorid
N'-(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-ylcarbonyl-L-prolinamide
N“-(2R,3S)-5-chlór-3-(2-chlórfenyl)-1-[(3,4-dimetylfenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-ylkarbonyl-L-prolínamid
(3S)-tetrahydrofuran-3-yl (1S,2R)-3-[(4-aminophenylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
[(3S)-oxolán-3-yl]-(1S,2R)-3-[(4-aminofenylsulfonyl)(izobutyl)amino]-1-benzyl-2-hydroxypropylkarbamát
4-[5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
4-[5-(4-metylfenyl)-3-(trifluórmetyl)-1H-pyrazol-1-yl]benzénsulfónamid
4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide
4-(4-cyklohexyl-4-metyl-1,3-oxazol-5-yl)-2-fluórbenzénsulfóamid
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
4-(5-metyl-3-fenyl-1,2-oxazol-4-yl)benzénsulfónamid
(S)-N-hydroxy-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxamide
(S)-N-hydroxy-2,2-dimetyl-4-[4-(4-pyridyloxy)fenylsulfonyl]-1,4-tiazinán-3-karboxamid
(2E)-but-2-enedioyl (INNCN)
(2E)-but-2-éndioyl (INNCN)
sulfate (INNRG)
sulfát (INNRG)
sulphate
sulphát
3-sulphobenzoate
3-sulphobenzoát
acetofenide
acetofenid
allylbromide
alylbromid
allyliodide
alyljodid
benzylbromide
benzylbromid
benzyliodide
benzyljodid
butylbromide
butylbromid
ethyliodide
etyljodid
fluorosulfonate
fluórsulfonát
hydrogen
vodík
sulfinate
sulfinát
sulfite
siričitan
sulphite
sulphit
sulfobenzoate
sulfobenzoát
sulfosalicylate
sulfosalicylát
2,2',2''-nitrilotriethanol (INNCN)
2,2',2''-nitrilotrietanol (INNCN)
3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
3H-[1,2,3]triazolo[4,5-b]pyridín-3-ol
1-acetoxyethyl
1-acetoxyetyl
1-(acetyloxy)ethyl
1-(acetyloxy)etyl
(acetyloxy)methyl (INNCN)
(acetyloxy)metyl (INNCN)
allyl
alyl
2-(dimethylamino)-2-oxoethyl (INNCN)
2-(dimetylamino)-2-oxoetyl (INNCN)
rac-1-(acetyloxy)ethyl (INNCN)
rac-1-(acetyloxy)etyl (INNCN)
(benzoyloxy)methyl (INNCN)
(benzoyloxy)metyl (INNCN)
cituxetan (INNRG)
cituxetán (INNRG)
2-(dimethylamino)ethyl (INNCN)
2-(dimetylamino)etyl (INNCN)
2-(2-hydroxyethoxy)ethyl (INNCN)
2-(2-hydroxyetoxy)etyl (INNCN)
2-(pyrrolidin-1-yl)ethanol (INNCN)
2-(pyrolidín-1-yl)etanol (INNCN)
ethyl
etyl
isopropyl
izopropyl
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (INNCN)
(5-metyl-2-oxo-1,3-dioxol-4-yl)metyl (INNCN)
1-deoxy-1-methylamino-D-glucitol
1-deoxy-1-metylamino-D-glucitol
(RS)-1-[(2,2-dimethylpropanoyl)oxy]ethyl (INNCN)
(RS)-1-[(2,2-dimetylpropanoyl)oxy]etyl (INNCN)
rac-1-[(2-methoxy-2-methylpropanoyl)oxy]ethyl (INNCN)
rak-1-[(2-metoxy-2-metylpropanoyl)oxy]etyl (INNCN)
(pivaloyloxy)methyl
(pivaloyloxy)metyl
[(2,2-dimethylpropanoyl)oxy]methyl (INNCN)
[(2,2-dimetylpropanoyl)oxy]metyl (INNCN)
3-sulfobenzoate
3-sulfobenzoát
tetraxetan (INNRG)
tetraxetán (INNRG)
rac-(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl (INNCN)
rac-(2R)-2,5,7,8-tetrametyl-2-[(4R,8R)-4,8,12-trimetyltridecyl]chróman-6-yl (INNCN)
(E)-6,6-dimethylhept-2-en-4-yn-1-ol
(E)-6,6-dimetylhept-2-én-4-yl-1-ol
(2R)-2-aminopropan-1-ol
(2R)-2-aminopropán-1-ol
(2-butylimidazol-5-yl)methanol
(2-butylimidazol-5-yl)metanol
2-5-[(1H-1,2,4-triazol-1-yl)methyl]indol-3-ylethan-1-ol
2-5-[(1H-1,2,4-triazol-1-yl)metyl]indol-3-yletán-1-ol
(RS)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol
(RS)-3-(dimetylamino)-1-(2-tienyl)propán-1-ol
(1S)-3-(methylamino)-1-(2-thienyl)propan-1-ol
(1S)-3-(metylamino)-1-(2-tienyl)propán-1-ol
F.-W. Steinmeier
F.-W Steinmeier
Commission Regulation (EC) No 130/2007
Nariadenie Komisie (ES) č. 130/2007
of 13 February 2007
z 13. februára 2007,
This Regulation shall enter into force on 14 February 2007.
Toto nariadenie nadobúda účinnosť 14. februára 2007.
Done at Brussels, 13 February 2007.
V Bruseli 13. februára 2007
to Commission Regulation of 13 February 2007 establishing the standard import values for determining the entry price of certain fruit and vegetables
k nariadeniu Komisie z 13. februára 2007, ktorým sa určujú paušálne dovozné hodnoty na určovanie vstupných cien určitých druhov ovocia a zeleniny
Commission Regulation (EC) No 131/2007
Nariadenie Komisie (ES) č. 131/2007
amending Regulation (EC) No 990/2006 as regards the quantities covered by standing invitations to tender for the export of common wheat and barley held by the intervention agencies of certain Member States
ktorým sa mení a dopĺňa nariadenie (ES) č. 990/2006, pokiaľ ide o množstvá, na ktoré sa vzťahujú stále verejné súťaže na vývoz pšenice obyčajnej a jačmeňa v držbe intervenčných agentúr niektorých členských štátov
Commission Regulation (EC) No 990/2006 [2] opened standing invitations to tender for the export of cereals held by the intervention agencies of the Member States.
Nariadením Komisie (ES) č. 990/2006 [2] boli vyhlásené stále verejné súťaže na vývoz obilnín v držbe intervenčných agentúr členských štátov.
Economic operators have not submitted tenders for some of the cereals covered by these tenders for several weeks now, apart from recent bids for small quantities. This is due in particular to the more favourable conditions for resale on the internal market under Commission Regulation (EC) No 1483/2006 of 6 October 2006 opening standing invitations to tender for the resale on the Community market of cereals held by the intervention agencies of the Member States [3].
Pre niektoré z obilnín dotknutých týmito verejnými súťažami hospodárske subjekty nepredložili ponuky už niekoľko týždňov, s výnimkou nedávno podaných ponúk na malé množstvá, predovšetkým z dôvodu výhodnejších podmienok ďalšieho predaja na vnútornom trhu v rámci nariadenia Komisie (ES) č. 1483/2006 zo 6. októbra 2006, ktorým sa otvárajú stále verejné súťaže na ďalší predaj obilnín v držbe intervenčných agentúr členských štátov na trhu Spoločenstva [3].
Resale on the internal market has increased sharply over that period.
Ďalší predaj na vnútornom trhu sa počas uvedeného obdobia výrazne zvýšil.
In view of this situation and in order to make the quantities of common wheat and barley currently blocked in respect of the standing invitations to tender under Regulation (EC) No 990/2006 available for resale on the internal market, the quantities covered by those invitations to tender should be reduced, in the case of common wheat, by 968 tonnes for the Czech Republic, 199946 tonnes for Hungary and 91 tonnes for Slovakia, and, in the case of barley, by 342 tonnes for Lithuania, 19011 tonnes for Hungary and 356 tonnes for Poland.
Vzhľadom na túto situáciu a s cieľom umožniť ďalší predaj na vnútornom trhu tých množstiev pšenice obyčajnej a jačmeňa, ktoré sú v súčasnosti blokované na základe stálych verejných súťaží v rámci nariadenia (ES) č. 990/2006, je vhodné znížiť množstvá pokryté uvedenými verejnými súťažami o 968 ton pre Českú republiku, o 199946 ton pre Maďarsko a o 91 ton pre Slovensko, pokiaľ ide o pšenicu obyčajnú, a o 342 ton pre Litvu, o 19011 ton pre Maďarsko a o 356 ton pre Poľsko, pokiaľ ide o jačmeň.
Regulation (EC) No 990/2006 should therefore be amended accordingly.
Nariadenie (ES) č. 990/2006 by sa preto malo zmeniť a doplniť.
Annex I to Regulation (EC) No 990/2006 is hereby replaced by the text in the Annex to this Regulation.
Príloha I k nariadeniu (ES) č. 990/2006 sa nahrádza textom uvedeným v prílohe k tomuto nariadeniu.
Regulation as last amended by Regulation (EC) No 37/2007 (OJ L 11, 18.1.2007, p. 3).
Nariadenie naposledy zmenené a doplnené nariadením (ES) č. 37/2007 (Ú. v. EÚ L 11, 18.1.2007, s. 3).
Regulation as last amended by Regulation (EC) No 91/2007 (OJ L 22, 31.1.2007, p. 5).
Nariadenie naposledy zmenené a doplnené nariadením (ES) č. 91/2007 (Ú. v. EÚ L 22, 31.1.2007, s. 5).
Commission Regulation (EC) No 132/2007
Nariadenie Komisie (ES) č. 132/2007
amending Regulation (EC) No 1483/2006 as regards the quantities covered by the standing invitation to tender for the resale on the Community market of cereals held by the intervention agencies of the Member States
ktorým sa mení a dopĺňa nariadenie (ES) č. 1483/2006, pokiaľ ide o množstvá určené pre stálu verejnú súťaž na ďalší predaj obilnín v držbe intervenčných agentúr členských štátov na trhu Spoločenstva
In view of the situation on the Community markets for common wheat and barley and of the changes in demand for cereals in various regions in recent weeks, new quantities of cereals held in intervention should be made available in some Member States.
Vzhľadom na situáciu na trhoch s pšenicou obyčajnou a jačmeňom v Spoločenstve a na zistený vývoj dopytu po obilninách v rôznych regiónoch za posledné týždne sa javí ako nutné sprístupniť v niektorých členských štátoch nové množstvá obilnín v držbe na intervenciu. Preto je potrebné povoliť intervenčným agentúram v príslušných členských štátoch zvýšiť množstvá ponúkané vo verejnej súťaži.
The intervention agencies in the Member States concerned should therefore be authorised to increase the quantities put out to tender by 598269 tonnes of common wheat in Germany and by 100000 tonnes of common wheat and 19011 tonnes of barley in Hungary.
Toto zvýšenie sa týka pšenice obyčajnej do výšky 598269 ton v Nemecku, 100000 ton v Maďarsku a jačmeňa do výšky 19011 ton v Maďarsku.
Commission Regulation (EC) No 133/2007
Nariadenie Komisie (ES) č. 133/2007
setting the allocation coefficient for issuing of licences applied for from 5 to 9 February 2007 to import sugar products under tariff quotas and preferential agreements
ktorým sa stanovuje koeficient pridelenia na vydávanie dovozných povolení od 5. do 9. februára 2007 na produkty cukru v rámci colných kvót a preferenčných dohôd
Applications for import licences were submitted to the competent authority during the week of 5 to 9 February 2007, in accordance with Regulation (EC) No 950/2006 or Commission Regulation (EC) No 1832/2006 of 13 December 2006 laying down transitional measures in the sugar sector by reason of the accession of Bulgaria and Romania [3] for a total quantity equal to or exceeding the quantity available for serial number 09.4347.
Žiadosti o dovozné povolenia na celkové množstvo boli v týždni od 5. do 9. februára 2007 predložené príslušným orgánom v súlade s nariadením (ES) č. 950/2006 alebo nariadením Komisie (ES) č. 1832/2006 z 13. decembra 2006, ktorým sa ustanovujú prechodné opatrenia v sektore cukru z dôvodu pristúpenia Bulharska a Rumunska [3], ktoré sa rovná alebo prevyšuje dostupné množstvo pod poradovým číslom 09.4347.
Licences shall be issued within the quantitative limits set in the Annex to this Regulation in respect of applications for import licences submitted from 5 to 9 February 2007, in accordance with Article 4(2) of Regulation (EC) No 950/2006 or Article 5 of Regulation (EC) No 1832/2006.
Pre žiadosti o dovozné povolenia predložené od 5. do 9. februára 2007 v súlade s článkom 4 ods. 2 nariadenia (ES) č. 950/2006 alebo v súlade s článkom 5 nariadenia (ES) č. 1832/2006 sa povolenia vydávajú v rozmedzí množstvových limitov uvedených v prílohe k tomuto nariadeniu.
Week of 5 to 9 February 2007: % of requested quantity to be granted
Percentuálny podiel na vydanie z množstva požadovaného v týždni od 5. do 9. februára 2007
Corrigendum to Commission Regulation (EC) No 134/2007 of 13 February 2007 fixing the A1 and B export refunds for fruit and vegetables (tomatoes, oranges, lemons, table grapes and apples)
Korigendum k nariadeniu Komisie (ES) č. 134/2007 z 13. februára 2007, ktorým sa určujú vývozné náhrady v rámci systémov A 1 a B za ovocie a zeleninu (rajčiny, pomaranče, citróny, stolové hrozno a jablká)
(Official Journal of the European Union L 42 of 14 February 2007)
(Úradný vestník Európskej únie L 42 zo 14. februára 2007)